AQP4 and Alzheimer disease: By using mice expressing APP and presenilin-1 (PS1) to increase Aβ production as a model for AD, they found that deleting the gene encoding for AQP4 resulted in a significant decrease in glymphatic clearance and extracellular accumulation of Aβ, but not this was severe enough to reach the point of Aβ plaque formation.